Skip to main content

HubXchange

HubXChange logo

Immunotherapies Xchange - San Francisco - 2025

Page Banner 1

  1. Immune Biomarkers
    • Immune Biomarkers
    AI-powered multiplex biomarker interpretation pipelines
    Dinesh Kumar, Ph.D
    Dinesh Kumar, Ph.D, Head of Translational Research Bioinformatics - Roche
  2. Immune Biomarkers
    • Immune Biomarkers
    Poster Presentation:
  3. Immune Regulation
    • Immune Regulation
    Poster Presentation:
  4. Immune Biomarkers
    • Immune Biomarkers
    Digital biomarkers from wearable and implantable devices
  5. Clinical Development
    • Clinical Development
    Clinical Trials in Rare Oncology Disease Indications
    Is the inclusion of a control arm appropriate in rare indications? What role would synthetic arms ap ...
    Anthony Maida
    Anthony Maida, Chief Clinical Officer - Translational Medicine - Oncotelic Therapeutics
  6. Immune Biomarkers
    • Immune Biomarkers
    Advancing neoantigen identification and immune monitoring: From discovery to clinical validation
    Léila Delamarre
    Léila Delamarre, Distinguished Scientist and Director, Cancer Immunology Discovery - Genentech
  7. Immunogenicity
    • Immunogenicity
    Impact of formulation and delivery systems on immunogenic potential
  8. Clinical Development
    • Clinical Development
    Patient-reported outcomes (PROs) in immunotherapy trials
  9. Translational Immunology
    • Translational Immunology
    Poster Presentation:
  10. Clinical Development
    • Clinical Development
    Assessing clinical trial designs in advancing novel immunotherapeutic drugs
    Venita DeAlmeida
    Venita DeAlmeida, Clinical Science Lead - 3T Biosciences
  11. Clinical Development
    • Clinical Development
    Poster Presentation:
  12. Immunogenicity
    • Immunogenicity
    Poster Presentation:
  13. Immune Regulation
    • Immune Regulation
    Designing synthetic gene circuits for programmable immune tolerance

    Iqvia Laboratories

  14. Translational Immunology
    • Translational Immunology
    IL-10's translational implications in human biology (Topic TBC)
    Vikash J. Bhagwandin
    Vikash J. Bhagwandin, Founding Scientist - VincaStemyx
  15. Immune Regulation
    • Immune Regulation
    Expanding and transferring regulatory T cells to enhance immune tolerance
    Olivier Nolan-Stevaux, Ph.d,
    Olivier Nolan-Stevaux, Ph.d,, Senior Director, Oncology Research - Gilead Sciences, Inc.
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Afternoon Refreshments
  17. Translational Immunology
    • Translational Immunology
    Translational immunology towards precision immunotherapy for autoimmune diseases
    Stefanie Mandl-Cashman
    Stefanie Mandl-Cashman, Chief Science Officer - Indapta Therapeutics
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Evening Drinks Reception
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Spotlight Presentation:
    Spotlight Presentation:
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Networking Lunch
  23. Translational Immunology
    • Translational Immunology
    Translating immune aging research into therapeutic interventions

    Ultivue

    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Morning Refreshments
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    1-2-1 Meetings / Networking Break
  27. Immune Regulation
    • Immune Regulation
    Immune metabolic pathways in maintaining tolerance
    Recent advances in our understanding of immune cell metabolic pathways, and their driving role in in ...
    Greg Timblin
    Greg Timblin, CEO & Co-Founder - Inapill
  28. Clinical Development
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Spotlight Presentation:
    Spotlight Presentation:
  29. Immunogenicity
    • Immunogenicity
    Modulating the immune response to prevent immunogenicity/anti-drug antibodies
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Opening Address & Keynote Presentation:
    • Immunogenicity
    • Immune Regulation
    • Translational Immunology
    • Immune Biomarkers
    • Clinical Development
    Registration
Search